| Literature DB >> 24900494 |
Jiangli Song1, Lindsay M Jones1, G D Kishore Kumar1, Elizabeth S Conner1, Liela Bayeh1, Gustavo E Chavarria1, Amanda K Charlton-Sevcik1, Shen-En Chen1, David J Chaplin2, Mary Lynn Trawick1, Kevin G Pinney1.
Abstract
A series of 36 thiosemicarbazone analogues containing the thiochromanone molecular scaffold functionalized primarily at the C-6 position were prepared by chemical synthesis and evaluated as inhibitors of cathepsins L and B. The most promising inhibitors from this group are selective for cathepsin L and demonstrate IC50 values in the low nanomolar range. In nearly all cases, the thiochromanone sulfide analogues show superior inhibition of cathepsin L as compared to their corresponding thiochromanone sulfone derivatives. Without exception, the compounds evaluated were inactive (IC50 > 10000 nM) against cathepsin B. The most potent inhibitor (IC50 = 46 nM) of cathepsin L proved to be the 6,7-difluoro analogue 4. This small library of compounds significantly expands the structure-activity relationship known for small molecule, nonpeptidic inhibitors of cathepsin L.Entities:
Keywords: cathepsin B; cathepsin L; inhibitor; thiochromanone; thiosemicarbazone
Year: 2012 PMID: 24900494 PMCID: PMC4025852 DOI: 10.1021/ml200299g
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345